EMBC vs OFIX: fair value comparison
Embecta Corp. and Orthofix Medical Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, EMBC currently sits closer to the top of our discount ranking. EMBC carries the stronger quality grade.
| EMBC | OFIX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $5.25 | $9.43 |
| 12-month range | $3.28–$14.24 | $9.27–$16.06 |
| Sector rank | #10 of 113 Healthcare | #13 of 113 Healthcare |
| Quality grade | B | F |
| Momentum grade | B | — |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Mixed |
| DCF cross-check | Undervalued | — |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: EMBC fair value analysis · OFIX fair value analysis